Connectus Wealth »

BioMarin Pharmaceutical shares owned by Connectus Wealth

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Connectus Wealth from 13F filings

Historical chart of Connectus Wealth investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Connectus Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Connectus Wealth

Quarter filed Position value Share count Share price at filing
2023-09-30 $266k 3.0k 88.48
2023-06-30 $261k 3.0k 86.68

More positions owned by Connectus Wealth

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf (SPY)
Amazon (AMZN)
MasterCard Incorporated (MA)
Alphabet Inc Class C cs (GOOG)
Thermo Fisher Scientific (TMO)
iShares S&P 500 Index (IVV)
Costco Wholesale Corporation (COST)
iShares Lehman MBS Bond Fund (MBB)
Alphabet Inc Class A cs (GOOGL)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
J P Morgan Exchange Traded F ultra shrt (JPST)
Invesco Exchange W&p 500 Qualit equities (SPHQ)

View all positions for Connectus Wealth

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings
T. Rowe Price Associates

View all funds holding BioMarin Pharmaceutical